There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Erasca (ERAS – Research Report) and Disc Medicine (IRON – Research Report) with bullish sentiments.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ERAS:
- Erasca Secures Funding for Future Growth Through Private Placement
- Erasca Announces $45 Million Oversubscribed Private Placement Financing
- Erasca reports Q4 EPS (20c), consensus (23c)
- Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
- ERAS Earnings this Week: How Will it Perform?
